Skip to main content
TipRanks
Go Ultimate75% OFF

John Nicholson Insider Profile

4 Followers

John Nicholson, SVP & Chief Operating Officer at Nektar Therapeutics, holds 162.76K shares in Nektar Therapeutics (Ticker: NKTR).

John Nicholson's Trading History

NKTR
Nektar Therapeutics
Aug 19, 2019SVP & Chief Operating OfficerUninformative Sell69.31K$6.07M
NKTR
Insider Shares: 162.76K (0.09%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 19, 2019Uninformative Sell$69.31K3,819$18.15―
May 17, 2019Uninformative Sell$127.90K4,077$31.37―
Feb 21, 2019Uninformative Sell$162.01K3,822$42.39―
Jan 30, 2019Uninformative Sell$2.70M63,000$42.82―
Jan 30, 2019Uninformative Buy$673.47K63,000$10.69―

You May Also Like

John Nicholson insider profile FAQ

What is the percentage of profitable transactions made by John Nicholson?
The percentage of profitable transactions made by John Nicholson is 17%.
What is the average return per transaction made by John Nicholson?
The average return per transaction made by John Nicholson is -125.80%.
What stocks does John Nicholson hold?
John Nicholson holds: NKTR stocks.
What was John Nicholson’s latest transaction?
John Nicholson’s latest transaction was an Uninformative Sell of $69.31K.
What was John Nicholson's most profitable transaction?
John Nicholson’s most profitable transaction was an Informative Sell of NKTR stock on March 8, 2018. The return on the trade was 67.60%.
What is John Nicholson's role in Nektar Therapeutics?
John Nicholson's role in Nektar Therapeutics is SVP & Chief Operating Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.